Belleview Biosciences LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 15431 Flight Path Dr, Brooksville, Florida (FL) 34604, United States (USA)
- Operations here
- analysislabelmanufacturepackrepack
- FDA identifiers
- FEI 3005350897 · DUNS 131968803
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- OAIDrug Quality Assurance2024-03-15
- OAIDrug Quality Assurance2021-08-20
- OAIDrug Quality Assurance2019-02-15
- OAIDrug Quality Assurance2017-01-25
- VAIDrug Quality Assurance2014-04-01
- OAIDrug Quality Assurance2012-03-30
- OAIUnapproved and Misbranded Drugs2012-03-30
- VAIUnapproved and Misbranded Drugs2012-03-30
- NAIDrug Quality Assurance2010-11-24
- OAIDrug Quality Assurance2010-11-24
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- SODIUM CITRATE and CITRIC ACID MONOHYDRATEBelleview Biosciences LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.